Article
HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana.
Viruses - 31 Mar 2021
Seatla Kaelo K, Maruapula Dorcas, Choga Wonderful T, Ntsipe Tshenolo, Mathiba Nametso, Mogwele Mompati, Kapanda Max, Nkomo Bornapate, Ramaabya Dinah, Makhema Joseph, Mmalane Mompati, Mine Madisa, Kasvosve Ishmael, Lockman Shahin, Moyo Sikhulile, Gaseitsiwe Simani
Abstract excerpt
There are limited real-world mutational and virological outcomes data of treatment-experienced persons diagnosed with HIV-1 subtype C (HIV-1 C) who are failing Integrase Strand Transfer Inhibitor-based regimens. Requisition forms sent for HIV-1 genotypic resistance testing (GRT) between May 2015 and September 2019 were reviewed and participants experiencing virologic failure while on dolutegravir (DTG) or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
